Korean Journal of Internal Medicine

Papers
(The H4-Index of Korean Journal of Internal Medicine is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Predictors of recurrent acute myocardial infarction despite successful percutaneous coronary intervention68
Bilateral leg pain and swelling with abnormal imaging findings in a patient with voriconazole52
Clinical impact of pleural fluid carcinoembryonic antigen on therapeutic strategy and efficacy in lung adenocarcinoma patients with malignant pleural effusion43
Assessment and nonsurgical management of low back pain: a narrative review42
Clinical outcomes of and risk factors for secondary infection in patients with severe COVID-19: a multicenter cohort study in South Korea36
Incidence and risk factors of immune checkpoint inhibitor-induced colitis in Korean patients with cancer35
Helicobacter pylori infection and iron deficiency in non-elderly adults participating in a health check-up program30
Clinical features and signaling effects of RET D631Y variant multiple endocrine neoplasia type 2 (MEN2)29
Public interest in the digital transformation accelerated by the COVID-19 pandemic and perception of its future impact28
Disseminated tuberculosis without pulmonary involvement mimicking multiple bone metastases27
Korean physician prescription patterns for home oxygen therapy in chronic obstructive pulmonary disease patients25
Current perspectives on sarcopenia: diagnosis and therapeutic approaches25
Call for evidence mapping in accordance with the changing features of invasive pulmonary aspergillosis during the coronavirus disease 2019 pandemic25
Decompensated cirrhosis and antibiotic prophylaxis: striking a delicate balance24
Clinical and epidemiological implications of the data on the Korean clinical hypertension cohort24
Impaired aldosterone response to potassium and hyperkalemia in patients receiving a renin-angiotensin-aldosterone system inhibitor24
Sex-specific impact of the COVID-19 outbreak on the incidence of metabolic syndrome: a comparative study of 2018–2019 and 2020–202123
Microbiologic pattern and clinical outcome of non-ICU-acquired pneumonia: Korean HAP registry analysis23
Timing and predictors of death during treatment in patients with multidrug/rifampin-resistant tuberculosis in South Korea22
Clinical efficacy of angiotensin receptor-neprilysin inhibitor in de novo heart failure with reduced ejection fraction21
0.097416877746582